货号 |
中文品名 |
英文品名 |
CAS No |
纯度 |
规格 |
32217059 |
(1R,2R)-2-(蒽-2,3-二甲酰亚胺基)环己甲酸 |
(1R,2R)-2-(Anthracene-2,3-dicarboximido)cyclohexanecarboxylic Acid |
446044-44-6 |
>980%(T) |
100mg |
32217060 |
(1S,2S)-2-(蒽-2,3-二甲酰亚胺基)环己甲酸 |
(1S,2S)-2-(Anthracene-2,3-dicarboximido)cyclohexanecarboxylic Acid |
446044-45-7 |
>970%(HPLC) |
100mg |
32217061 |
DBD-COCl [=4-(N,N-二甲基氨磺酰)-7-(N-氯甲酰甲基-N-甲氨基)-2,1,3-苯并恶二唑] |
DBD-COCl [=4-(N,N-Dimethylaminosulfonyl)-7-(N-chloroformylmethyl-N-methylamino)-2,1,3-benzoxadiazole] [for HPLC Labeling] |
156153-43-4 |
>980%(T) |
100mg |
32217062 |
(S)-(-)-DBD-Pro-COCl [=(S)-(-)-4-(N,N-二甲氨基磺酰基)-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(S)-(-)-DBD-Pro-COCl [=(S)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
150993-63-8 |
>900%(HPLC) |
100mg |
32217063 |
(R)-(+)-DBD-Pro-COCl [=(R)-(+)-4-(N,N-二甲氨基磺酰基)-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(R)-(+)-DBD-Pro-COCl [=(R)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
150993-62-7 |
>950%(HPLC) |
100mg |
32217064 |
(R)-(+)-NBD-Pro-COCl [=(R)-(+)-4-硝基-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(R)-(+)-NBD-Pro-COCl [=(R)-(+)-4-Nitro-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
159717-69-8 |
|
100mg |
32217065 |
(S)-(-)-NBD-Pro-COCl [=(S)-(-)-4-硝基-7-(2-氯甲酰四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(S)-(-)-NBD-Pro-COCl [=(S)-(-)-4-Nitro-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
159717-68-7 |
>980%(HPLC) |
100mg |
32217066 |
(R)-(-)-DBD-Py-NCS [=(R)-(-)-4-(N,N-二甲氨基磺酰基)-7-(3-异硫氰酸基四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(R)-(-)-DBD-Py-NCS [=(R)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling] |
163927-31-9 |
>980%(HPLC) |
100mg |
32217067 |
(S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-二甲氨基磺酰基)-7-(3-异硫氰酸基四氢吡咯-1-基)-2,1,3-苯并恶二唑] |
(S)-(+)-DBD-Py-NCS [=(S)-(+)-4-(N,N-Dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [for HPLC Labeling] |
163927-32-0 |
>980%(HPLC) |
100mg |
32217068 |
NBD-COCl [=4-(N-氯甲酰甲基-N-甲氨基)-7-硝基-2,1,3-苯并恶二唑] |
NBD-COCl [=4-(N-Chloroformylmethyl-N-methylamino)-7-nitro-2,1,3-benzoxadiazole] [for HPLC Labeling] |
140164-85-8 |
>920%(T) |
100mg/1g |
32217069 |
DBD-NCS [=4-(N,N-二甲基氨磺酰)-7-异硫氰酸基-2,1,3-苯并恶二唑] |
DBD-NCS [=4-(N,N-Dimethylaminosulfonyl)-7-isothiocyanato-2,1,3-benzoxadiazole] [for HPLC Labeling and Edman Degradation] |
147611-81-2 |
>980%(HPLC) |
100mg |
32217070 |
(R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-异硫氰酸基吡咯烷-1-基)-7-硝基-2,1,3-苯并恶二唑] |
(R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
163927-29-5 |
>980%(HPLC) |
100mg |
32217071 |
(S)-(+)-NBD-Py-NCS [=(S)-(+)-4-(3-异硫氰酸基吡咯烷-1-基)-7-硝基-2,1,3-苯并恶二唑] |
(S)-(+)-NBD-Py-NCS [=(S)-(+)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for ee Determination] |
163927-30-8 |
>980%(HPLC) |
100mg |
32217072 |
4-(4,5-二苯基-1H-咪唑-2-基)苯甲酰氯盐酸盐 |
4-(4,5-Diphenyl-1H-imidazol-2-yl)benzoyl Chloride Hydrochloride [for HPLC Labeling] |
|
>970%(T) |
100mg |
32217073 |
NBD-Cl (=4-氯-7-硝基-2,1,3-苯并恶二唑) |
NBD-Cl (=4-Chloro-7-nitro-2,1,3-benzoxadiazole) [for HPLC Labeling] |
10199-89-0 |
>980%(T) |
1g/5g |
32217074 |
NBD-F (=4-氟-7-硝基-2,1,3-苯并恶二唑) |
NBD-F (=4-Fluoro-7-nitro-2,1,3-benzoxadiazole) [for HPLC Labeling] |
29270-56-2 |
>990%(HPLC) |
100mg |
32217075 |
2,3-萘二醛 |
2,3-Naphthalenedialdehyde [Fluorimetric reagent for primary Amines] |
7149-49-7 |
>990%(GC) |
100mg/1g |
32217076 |
DBD-F[=4-(N,N-二甲氨基磺酰)-7-氟-2,1,3-苯并恶二唑] |
DBD-F [=4-(N,N-Dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole] [for HPLC Labeling] |
98358-90-8 |
>980%(HPLC) |
100mg |
32217077 |
丹磺酰氯(10%的丙酮溶液) |
Dansyl Chloride (10% in Acetone) |
605-65-2 |
|
10mL |
32217078 |
丹磺酰氯 |
Dansyl Chloride |
605-65-2 |
>980%(HPLC)(T) |
1g/5g/25g |
32217079 |
6-[[7-(N,N-二甲氨基磺酰)-2,1,3-苯并恶二唑-4-基]氨基]己酸 |
6-[[7-(N,N-Dimethylaminosulfonyl)-2,1,3-benzoxadiazol-4-yl]amino]hexanoic Acid |
|
>980%(T)(HPLC) |
100mg |
32217080 |
异硫氰酸荧光素(异构体I) |
Fluorescein 5-Isothiocyanate (isomer I) |
3326-32-7 |
|
100mg |
32217081 |
荧光胺 |
Fluorescamine [for HPLC Labeling] |
38183-12-9 |
|
100mg/1g |
32217082 |
氯甲酸-9-芴甲酯 |
9-Fluorenylmethyl Chloroformate [N-Protecting Agent for Peptides Research] |
28920-43-6 |
>970%(HPLC)(T) |
5g/25g/100g |
32217083 |
荧光素-6-异硫氰酸酯(同分异构体II) |
Fluorescein 6-Isothiocyanate (isomer II) |
18861-78-4 |
>970%(HPLC)(T) |
100mg |
32217084 |
异硫氰酸荧光素(5-,6-异构体混合物) |
Fluorescein Isothiocyanate (mixture of 5- and 6- isomers) |
27072-45-3 |
>970%(HPLC)(T) |
100mg/1g |
32217085 |
2-甲氧基-2,4-二苯基-3(2H)-呋喃酮 |
2-Methoxy-2,4-diphenyl-3(2H)-furanone |
50632-57-0 |
>980%(HPLC) |
100mg/1g |
32217086 |
(1R,2R)-2-(萘-2,3-二甲酰亚胺基)环己甲酸 |
(1R,2R)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid |
642995-15-1 |
>980%(HPLC)(T) |
100mg |
32217087 |
(1S,2S)-2-(萘-2,3-二甲酰亚胺基)环己甲酸 |
(1S,2S)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid |
642995-16-2 |
>980%(HPLC)(T) |
100mg |
32217088 |
邻苯二甲醛 |
o-Phthalaldehyde [for HPLC Labeling] |
643-79-8 |
>990%(GC) |
5g/25g/100g |
32217089 |
6-[[7-(N,N-二甲氨基磺酰)-2,1,3-苯并恶二唑-4-基]氨基]己酸琥珀酰亚胺酯 |
Succinimidyl 6-[[7-(N,N-Dimethylaminosulfonyl)-2,1,3-benzoxadiazol-4-yl]amino]hexanoate |
|
>980%(HPLC) |
100mg |